| Patient characteristic | Total (N=1430) | CD4 ≤200 cells/μl (n=743, 52.0%) | CD4 201–350 cells/μl (n=687, 48.0%) |
|---|---|---|---|
| Sex, n (%) | |||
| Female | 991 (69.3) | 471 (63.4) | 520 (75.7) |
| Male | 439 (30.7) | 272 (36.6) | 167 (24.3) |
| Age at HIV testing, median (IQR) | 34.3 (29.3, 41.2) | 35.2 (30.0, 42.2) | 33.3 (28.7, 39.9) |
| Age at HIV testing, n (%) | |||
| 18–29 years | 400 (28.0) | 182 (24.5) | 218 (31.7) |
| 30–39 years | 625 (43.7) | 327 (44.0) | 298 (43.4) |
| 40 years and older | 405 (28.3) | 234 (31.5) | 171 (24.9) |
| First CD4 value (cells/mm3), median (IQR) | 195 (103, 266) | 105 (55, 154) | 268 (239, 307) |
| First CD4 value, n (%) | |||
| <50 cells/μl | 169 (11.8) | 169 (22.8) | 0 (0.0) |
| 50–100 cells/μl | 182 (12.7) | 182 (24.5) | 0 (0.0) |
| 101–200 cells/μl | 392 (27.4) | 392 (52.8) | 0 (0.0) |
| 201–350 cells/μl | 687 (48.0) | 0 (0.0) | 687 (100.0) |
| Nationality, n (%) | |||
| Born in South Africa | 969 (67.8) | 504 (67.8) | 465 (67.7) |
| Born outside of South Africa | 461 (32.2) | 239 (32.2) | 222 (32.3) |
| Employment status, n (%) | |||
| Employed | 736 (51.5) | 391 (52.6) | 345 (50.2) |
| Not employed | 694 (48.5) | 352 (47.4) | 342 (49.8) |
| TB at ART initiation, n (%) | |||
| No | 1267 (88.6) | 619 (83.3) | 648 (94.3) |
| Yes | 163 (11.4) | 124 (16.7) | 39 (5.7) |
| Pregnant at ART initiation, n (%) | |||
| No | 1219 (85.2) | 664 (89.4) | 555 (80.8) |
| Yes | 211 (14.8) | 79 (10.6) | 132 (19.2) |
IQR, interquartile range